The risk of fractures in postmenopausal women with primary hyperparathyroidism

被引:65
作者
De Geronimo, Simona [1 ]
Romagnoli, Elisabetta [1 ]
Diacinti, Daniele [1 ]
D'Erasmo, Emilio [1 ]
Minisola, Salvatore [1 ]
机构
[1] Univ Roma La Sapienza, Dept Clin Sci, I-00161 Rome, Italy
关键词
D O I
10.1530/eje.1.02225
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Objective: To evaluate the prevalence of vertebral (vFr) and non-vertebral (nvFr) fractures in postmenopausal women with primary hyperparathyroidism (PHPT). Materials and Methods: We studied 9 8 patients with PHPT, divided into 'mild' (M, n = 25) and 'non-mild' (NM, n = 73) sub-groups, according to recently published guidelines (2002), and 89 healthy women (C) matched for age, years since menopause and body mass index. vFr was evaluated according to a visual semiquantitative method; bone mineral density (BMD) at the lumbar spine (LS), and femoral sites (femoral neck, FN and total femur, FT) was measured by dual energy X-ray absorptiometry. Volumetric BMD of the third lumbar vertebra (vBMDL3) was also calculated. Results: The prevalence of vFr was significantly higher (P < 0.001) in both M and NM PHPT patients compared with C; this prevalence did not differ between M and NM patients. BMD was significantly lower (P < 0.05) in NM patients compared with both C and M patients. BMD at LS in M patients was also significantly higher with respect to C. Similar results were also obtained for vBMDL3; in M patients, vBMDL3 was also significantly higher compared to C. When M and NM patients were subdivided according to the presence or lack of vFr, no difference was found between fractured and unfractured patients for either BMD or vBMDL3 values. Conclusions: The risk of vFr is higher in postmenopausal patients with mild PHPT even if BMD appears well preserved. This finding suggests that other factors, such as bone quality, seem to be relevant in determining fracture risk, especially when gonadal function is lacking.
引用
收藏
页码:415 / 420
页数:6
相关论文
共 29 条
[1]
Primary hyperparathyroidism: new concepts in clinical, densitometric and biochemical features [J].
Bilezikian, JP ;
Brandi, ML ;
Rubin, M ;
Silverberg, SJ .
JOURNAL OF INTERNAL MEDICINE, 2005, 257 (01) :6-17
[2]
Bilezikian JP, 2002, J BONE MINER RES, V17, pN57
[3]
Clinical practice - Asymptomatic primary hyperparathyroidism [J].
Bilezikian, JP ;
Silverberg, SJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (17) :1746-1751
[4]
Bone strength in primary hyperparathyroidism [J].
Bilezikian, JP .
OSTEOPOROSIS INTERNATIONAL, 2003, 14 (Suppl 5) :S113-S115
[5]
Bilezikian JP, 2004, CUR OPIN ENDOCRINOL, V11, P345
[6]
BISCHOFFFERRARI.HA, 2005, CURRENT OPINION ENDO, V2, P464
[7]
Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures [J].
Black, DM ;
Cummings, SR ;
Karpf, DB ;
Cauley, JA ;
Thompson, DE ;
Nevitt, MC ;
Bauer, DC ;
Genant, HK ;
Haskell, WL ;
Marcus, R ;
Ott, SM ;
Torner, JC ;
Quandt, SA ;
Reiss, TF ;
Ensrud, KE .
LANCET, 1996, 348 (9041) :1535-1541
[8]
Vitamin D status in female patients with primary hyperparathyroidism: does it play a role in skeletal damage? [J].
Carnevale, V ;
Manfredi, G ;
Romagnoli, E ;
De Geronimo, S ;
Paglia, F ;
Pepe, J ;
Scillitani, A ;
D'Erasmo, E ;
Minisola, S .
CLINICAL ENDOCRINOLOGY, 2004, 60 (01) :81-86
[9]
Effects of an excess and a deficiency of endogenous parathyroid hormone on volumetric bone mineral density and bone geometry determined by peripheral quantitative computed tomography in female subjects [J].
Chen, QX ;
Kaji, H ;
Iu, MF ;
Nomura, R ;
Sowa, H ;
Yamauchi, M ;
Tsukamoto, T ;
Sugimoto, T ;
Chihara, K .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (10) :4655-4658
[10]
Primary hyperparathyroidism and osteoporosis in 2004 [J].
Cormier, C ;
Souberbielle, JC ;
Kahan, A .
JOINT BONE SPINE, 2004, 71 (03) :183-189